Farallon Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-220,000	Closed	-$21.3M	–	127
2019 Q3	$21.3M	Sell	220,000 -550,000	-71%	-$53.3M	0.16%	72
2019 Q2	$78.8M	Sell	770,000 -50,000	-6%	-$5.12M	0.51%	43
2019 Q1	$93.4M	Buy	+820,000	New	+$93.4M	0.7%	38